Tuberculosis: open trials in Thailand

• NCT07124559

  A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

  Trial Treatment · Phase 1/2 · National Institute of Allergy and Infectious Diseases (NIAID)

  Siriraj Hospital, Mahidol University NICHD CRS (Site ID: 5115), Bangkok · Chiangrai Prachanukroh Hospital (Site ID: 5116), Chiang Rai

  Registry updated 2026-11-02

• NCT07595042

  A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

  Trial Treatment · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)

  Siriraj Hospital, Mahidol University NICHD CRS (Site # 5115), Bangkok · Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS (Site #: 31784), Chiang Mai · Chiangrai Prachanukroh Hospital NICHD CRS (Site # 5116), Chiang Rai · Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (Site #: 31802), Pathum Wan

  Registry updated 2026-08-19

• NCT05383742

  Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

  Trial Treatment · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)

  Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (Site ID: 31802), Bangkok · Siriraj Hospital, Mahidol University NICHD CRS (Site ID: 5115), Bangkok · Chiangrai Prachanukroh Hospital NICHD CRS (Site ID: 5116), Chiang Mai

  Registry updated 2026-06-02

• NCT05571735

  Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

  Research · University of Oxford

  Shoklo Malaria Research Unit (SMRU), Mae Ramat

  Registry updated 2026-04-13

• NCT06845618

  Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

  Research · University of Oxford

  Shoklo Malaria Research Unit (SMRU), Tak

  Registry updated 2026-04-13

All Tuberculosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error